Uploaded August 2026 | Updated September 2026, 2 weeks ago
GLP-1 medications are being used for more than weight loss, including treating heart and other chronic conditions such as kidney and liver disease and sleep apnea.
Now, researchers are also studying whether GLP-1 medications could play a role in treating addiction. Dr. Ania Jastreboff of Yale’s Obesity Research Center says researchers are studying patients with obesity and alcohol use disorder to determine whether semaglutide could help.
The clinical trial is still in its early stages, and researchers say there is still much to learn.
Watch our full Beyond the Scale series for more on the research, risks and benefits behind GLP-1 medications.
Visit nbcconnecticut.com for the latest in news, weather, entertainment, sports and other great content.
NBC CT Facebook facebook.com/NBCConnecticut
NBC CT Instagram instagram.com/nbcconnecticut
#nbc #nbcconnecticut #ConnectingYou #nbcct
Download the NBC Connecticut app: nbcconnecticut.app.link/NuGsXNFUWGb
GLP-1 medications are being used for more than weight loss, including treating heart and other chronic conditions such as kidney and liver disease and sleep apnea.
Now, researchers are also studying whether GLP-1 medications could play a role in treating addiction. Dr. Ania Jastreboff of Yale’s Obesity Research Center says researchers are studying patients with obesity and alcohol use disorder to determine whether semaglutide could help.
The clinical trial is still in its early stages, and researchers say there is still much to learn.
Watch our full Beyond the Scale series for more on the research, risks and benefits behind GLP-1 medications.
Visit nbcconnecticut.com for the latest in news, weather, entertainment, sports and other great content.
NBC CT Facebook facebook.com/NBCConnecticut
NBC CT Instagram instagram.com/nbcconnecticut
#nbc #nbcconnecticut #ConnectingYou #nbcct
Download the NBC Connecticut app: nbcconnecticut.app.link/NuGsXNFUWGb










